F or many years, it has been assumed that the outlook for cancer patients requiring mechanical ventilation (MV) is grim (1) (2) (3) . Life support measures mobilize a high share of health resources (4) and impinge substantial distress on the patients' families. Acute respiratory failure (ARF) developing in these patients is usually considered a consequence of an advanced pulmonary disease not responsive to supportive care (1) . However, it is reasonable to assume that the prognosis may vary according to the severity and causes of ARF, associated acute organ failures, comorbidities, and characteristics related to the underlying malignancy.
Over the past decade, this scenario has shifted with recent advances in MV (5, 6) and the benefits of noninvasive ventilation (NIV) in immunocompromised patients (7, 8) . As a result, overall survival rates of cancer patients (7, 9 -11) admitted to the intensive care unit (ICU) are improving. Moreover, some recent studies have proposed that classic predictors of outcome such as neutropenia (9, 12) and hematologic malignancy (11, 13, 14) may have lost their impact on mortality. Clearly, it is time for a reappraisal of predictors of mortality in critically ill cancer patients that may help to avoid forgoing critical care for those with a chance of survival. The identification of such predictors would also be helpful for the counseling of patients and their families. The present prospective study was conducted to identify clinical variables predictive of in-hospital death.
MATERIALS AND METHODS
Design and Setting. This was a prospective observational cohort study conducted between May 2000 and January 2004 at the Instituto Nacional de Cancer (INCA), Rio de Janeiro, Brazil. INCA is a 200-bed public hospital for the referral of cancer patients. The ICU is an exclusively oncologic 10-bed medical-surgical unit with medical, nursing, and physical therapy staff fully trained in intensive care. Routine clinical rounds and meetings with the oncologists take place daily at the ICU. Decisions to admit a patient to the ICU are regularly based on both the intensivists' and oncologists' clinical judgment and on ICU bed availability. To be admitted to the ICU, patients must usually be considered to have a potential chance of being cured or having their cancer controlled. End-of-life (EOL) care is offered in the ICU when a patient does not recover from an acute illness despite ICU care. Occasionally, patients may be admitted for a severe illness during the assessment of their cancer and/or therapeutic options. This as-sessment is performed as soon as possible, and EOL care is offered if specific treatment aimed at cancer cure or control can no longer be given. Additional information about the ICU organization and staff has been previously described (15) .
This study was approved by the Institutional Review Board, and informed consent was waived since the study did not interfere with clinical decisions related with patient care.
Selection of Participants, Data Collection, and Data Processing. During the study period, every adult patient (age Ն18 yrs) with a pathologically proven cancer and receiving MV during the first day of ICU for Ն24 hrs was evaluated. For patients with multiple admissions, only the first admission requiring MV was taken into account. Patients in complete cancer remission over 5 yrs and patients with acute coronary syndromes were not evaluated. At our institution, bone marrow transplant (BMT) patients are treated at a separate unit even in case of a life-threatening complication and, therefore, were not studied.
The following data were collected at admission and during the first 24 hrs of ICU stay: age, gender, the Simplified Acute Physiology Score (SAPS) II (16), Sequential Organ Failure Assessment (SOFA) (17) score, main diagnosis for ICU admission, severe chronic comorbidities, main reasons for ventilatory support, modality of MV (conventional MV or NIV), and the lowest PaO 2 /FIO 2 ratio. Patients were classified as either surgical or medical. Surgical patients were those who had undergone a surgical procedure (excluding biopsies and catheter insertions) before the ICU admission during the current hospital stay. The type of cancer, cancer status, anticancer treatments during the 6 months before ICU admission, and performance status (PS) at the week before hospital admission were also assessed. PS was evaluated according to the Eastern Cooperative Oncology Group scale, as follows: 0 -1, asymptomatic/ambulant; 2, requiring minor assistance for daily activities; 3-4, requiring major assistance or chronically bedridden (18) . Leukopenia was defined as a white blood cell count Ͻ1000/mm 3 . Severe chronic comorbidities were defined as follows: heart failure (New York Heart Association class III-IV); renal failure (chronic dialysis therapy); cirrhosis (Child-Pugh-Turcot class B or C); and chronic pulmonary obstructive disease (COPD; presence of airway obstruction on spirometry attributed to chronic bronchitis or emphysema) (19) . Individual acute organ failure was defined as a SOFA score Ն3 points for each system. The cancer was considered to be a direct reason for MV when there were bilateral metastatic nodules, carcinomatous lymphangitis, or tumoral masses resulting in airway obstruction, lung compression, or atelectasis. Sepsis was diagnosed using the definitions established by the American College of Chest Physicians/Society of Critical Care Medicine consensus conferences (20) .
The patient was considered to have an infection when there were clinical, laboratory, radiologic, and microbiological findings suggesting the presence of infection that justified the administration of antibiotics (excluding prophylaxis). At our ICU, the criteria employed for the diagnosis of infection are usually those from the Centers for Disease Control (21) . Leukopenic patients presenting with fever and receiving antibiotics were considered to have an infection. Acute respiratory distress syndrome was defined according to the criteria of the American-European consensus conference (22) . The follow-up of the patients proceeded until death or hospital discharge. The outcome of interest in the current study was in-hospital death from any cause.
At our ICU, patients are ventilated with microprocessed ventilators, and conventional MV or NIV is used according to the intensivist's judgment. In general, NIV through a face mask was used first when there was no limitation or contraindication (8) . The inspiratory oxygen concentration, pressure support, and positive end-expiratory levels were adjusted to obtain a tidal volume of 7-10 mL/kg, breath rate Ͻ25/min, and oxygen saturation Ն95%. To be considered a modality of ventilatory support, NIV had to be applied for Ն6 hrs/day. Patients who had first received NIV, irrespective of its duration, and subsequently required endotracheal intubation were considered as NIV failure. The attending physician made the decision to switch patients to conventional MV or to cease NIV. The conventional MV approach had some variations according to the physician and patient. Acute respiratory distress syndrome patients usually receive a protective ventilatory strategy with low tidal volumes and limiting plateau pressure (5, 6) .
Data Presentation and Statistical Analysis. The statistical analysis was carried out with SPSS for Windows, version 10.0 (SPSS, Chicago, IL). Continuous variables were presented as mean Ϯ SD or median (25-75% interquartile range [IQR] ) and compared, respectively, by Student's t-test or MannWhitney U test. Categorical variables were compared by Fisher's exact or chi-square tests (with Yates correction where applicable). To examine whether the relation between each continuous variable and the outcome was linear, the variable was categorized in four levels according to the quartiles of distribution. A logistic regression model having the four-level categorical variable as the covariate was fitted and coefficients were estimated for each level. The coefficients were then plotted against the midpoints of each respective stratum (23) . If there was evidence that the relation was nonlinear, the continuous variable was categorized. Therefore, age (24, 25) and PaO 2 /FIO 2 ratio (22, 26) were categorized using cutoffs points that were clinically relevant with previously published thresholds values. Categorical variables with multiple levels were coded as "dummy" variables, and the one with the lowest mortality was used as the reference.
Variables with p Ͻ .25 in the univariable analysis were selected to enter the multivariable analysis. A multivariable logistic regression model, having in-hospital mortality as the dependent variable, was fitted in a forward stepwise procedure (23) . The potential associations in both univariable and multivariable analyses were summarized by calculating odds ratios and corresponding 95% confidence intervals. SAPS II was not entered in the multivariable analysis concerning possible collinearity with SOFA score and because other independent variables are included in that scoring system (age, PaO 2 /FIO 2 ratio, underlying malignancy). The area under the receiver operating characteristic curve (AUROC) was used to evaluate the ability of model to discriminate between patients who lived from patients who died (discrimination) (27) . The Hosmer-Lemeshow goodness-of-fit test statistic was used to evaluate the agreement between the observed and expected number of patients who did or not die in the hospital across all of the strata of probabilities of death (calibration) (23) . A high p value (Ͼ.05) would indicate a good fit for the model. A two-tailed p Ͻ .05 was considered statistically significant.
RESULTS
Characterization of the Study Population. During the study period, 1,660 adult patients were admitted to the ICU, and 463 (28%) patients met the eligibility criteria. Of these patients, 20 (4%) were readmitted to the ICU during the same hospital stay (15 patients requiring MV) and 12 (3%) patients were readmitted during a subsequent hospital admission (four patients requiring MV).
In addition to the need of MV, 352 (76%) patients presented with associated acute organ failures. Main demographic and clinical characteristics and those related to the underlying malignancy are shown in Tables 1 and 2 , respectively. During the first day of ICU stay, 290 (63%) patients received vasopressors and 39 (8%) were treated with hemodialysis. The median duration of ICU stay was 9 (IQR, 4 -17) days, and the median duration of hospital stay was 21 (IQR, 10 -36) days.
Surgical patients were older (61.0 Ϯ 15.2 vs. 55.9 Ϯ 17.8 yrs) and had lower SAPS II (48.4 Ϯ 14.5 vs. 55.9 Ϯ 15.5, p Ͻ .001) and SOFA (7.3 Ϯ 3.1 vs. 8.8 Ϯ 3.8, p Ͻ .001) scores than medical patients. As expected, surgical patients were more prone to have solid tumor (96% vs. 64%, p Ͻ .001) and controlled cancer (76% vs. 36%, p Ͻ .001).
Mechanical Ventilatory Support. The main indications for MV are depicted in Table 3 . Among all patients, 325 (70%) had artificial airway in place before the ICU; 297 (64%) patients had already been intubated, and 28 (6%) patients underwent tracheostomy. Of the remaining 138 patients, 98 had at least one contraindication to receive NIV. Therefore, only 40 (9%) patients were identified as possibly eligible for NIV as first ventilatory strategy. At the end of the first day of ICU, 444 (96%) patients were on conventional MV and 19 (4%) patients received NIV. The most important reasons for NIV were sepsis (n ϭ 5), cardiogenic pulmonary edema (n ϭ 4), pulmonary embolism (n ϭ 4), pulmonary drug toxicity (n ϭ 2), neoplasm (n ϭ 2), myasthenic crisis (n ϭ 1), and acute COPD exacerbation (n ϭ 1). The median PaO 2 /FIO 2 ratio of NIV patients was 172 (IQR, 123-254). Overall, NIV failed in nine (47%) patients who subsequently required tracheal intubation for conventional MV. Eleven patients fulfilled the criteria for acute respiratory distress syndrome, and NIV was successful in six of them. Although there were 32 COPD patients, only three COPD patients were possibly eligible for NIV, but NIV was used in two patients. Median time from hospitalization to the beginning of MV was 3 (IQR, 1-8; range, 0 -62) days and median MV duration was 8 (IQR, 4 -14; range, 1-115) days.
Outcome Analysis. The ICU mortality was 50% (232 of 463) and hospital mortality was 64% (297 of 463). Decisions to withhold or withdraw treatment were implemented in 118 (25%) patients at a 3-14, p ϭ .244) . The results of univariable analysis of characteristics related to hospital mortality are shown in Table 4 .
Age, surgical status, performance status, cancer status, type of cancer, COPD, leukopenia, SOFA score, NIV use, PaO 2 / FIO 2 ratio, pulmonary sepsis, pulmonary embolism, and tumor-related reason for MV were entered in the logistic regression multivariable analysis. Six variables were independently associated with increased hospital mortality (Table 5 ). The type of cancer, the presence of leukopenia, and surgical status had no independent influence on mortality. The final logistic model had good discrimination (AUROC, 0.78; 95% confidence interval, 0.73-0.82) and was well calibrated ( 2 ϭ 13.432, p ϭ .098). The performance of SAPS II score was similar in our population (AUROC, 0.76; confidence interval 95%, 0.72-0.81) 2 ϭ 11.575, p ϭ .171). Among 53 patients who had airway/ pulmonary involvement or invasion by the tumor as one of the reasons for MV, 13 (25%) were discharged from the ICU. Only five (9%) patients were successfully released home. Their cancer diagnoses were breast cancer causing large pericardial and pleural effusions (n ϭ 1) and newly diagnosed lymphoma (n ϭ 2) or germ cell tumor (n ϭ 2).
DISCUSSION
We present the results of a large prospective cohort of cancer patients requiring MV in the first day of ICU because of severe illnesses. The development of ARF remains one of the foremost reasons for ICU admission of cancer patients (11, 12, 28 -31) , and it is encouraging that in recent years the survival rate of such patients seems to be improving (7, 9, 32) . Advances in oncology and intensive care are probably being translated into a better outcome. Nevertheless, MV is still associated with a very high risk of death (12, 28 -30, 33) . In addition, the mortality rate for MV cancer patients remains higher than that for patients with nonmalignant diseases (6, 24) . The ICU and hospital mortality rates in our patients were 50% and 64%, respectively. Previous studies of large cohorts of cancer patients, excluding those restricted to BMT patients, have reported mortality rates ranging from 67% to 83% (1, 2, 7, 9, 29) . Mortality may vary according to multidimensional characteristics such as mix of patients (e.g., number of BMT and surgical patients, cancer status), level of ICU support, severity of acute illness, and ICU policies (admission and discharge criteria, institution of EOL care). Moreover, it is likely that the reasons for MV institution also influence patients' outcome. Information regarding the impact of causes of MV in cancer patients is restricted. A worse prognosis was reported for patients with "sepsis/ shock-related" and acute hypoxia compared with postoperative ARF (1, 9) . Nevertheless, after adjustment for other characteristics, the only reason for MV associated with increased mortality was airway/pulmonary involvement by the cancer. All five patients discharged from the hospital in whom cancer had been directly implicated in the need for MV had potentially treatable or controllable diseases.
In ARF patients, death usually occurs as a consequence of multiple organ failure (34) . In most studies of outcome of ICU cancer patients, severe organ failures have been studied individually. Since no single severe organ failure can unequivocally predict death, the SOFA score was used to measure the global impact of associated organ failures. Not surprisingly, higher SOFA scores were strongly associated with increased mortality, in accordance with previous studies of patients with hematologic malignancies (35) and solid tumors (12) .
In the present study, age increase was associated with a worse outcome. The impact of age in critically ill cancer patients is controversial. Some authors have reported a worse outcome for older patients (11, 33) ; however, in most studies, age was not independent risk factor for death (1, 7, 12, 14, 28, 31 ). Although we have found age to be a strong predictor of death, decisions regarding the use of MV should not be taken solely on the basis of patient's age. This recommendation has been emphasized in literature (25) . However, Hamel et al. (36) reported that older age was associated with higher rates of decisions to withhold ventilatory support. Patients with poor PS and cancer recurrence/progression were at an increased risk of death. These findings have already been highlighted by previous studies (12, 28, 31) . Moreover, our data provide additional support to the recent observation that classic clinical predictors of mortality seem to be changing (7, 31, 33) .
Currently, few specific ventilatory interventions are able to improve the prognosis of cancer patients with ARF. NIV was demonstrated to reduce morbidity and mortality in immunosuppressed patients (8) and in cancer patients (7) . However, only a small group of our patients were eligible to receive NIV. Most of them already had an artificial airway in place before the ICU admission or presented with contraindications for NIV, thus limiting a more widespread use of this ventilatory approach. In addition, we were not able to determine how many patients had received NIV before ICU admission. The low number of patients might have limited the evaluation of NIV in multivariable analysis.
This study had a few other limitations. As previously described, we did not evaluate BMT patients since they were treated at a separate unit with different standards of care. In addition, we acknowledge that BMT patients have factors that differentiate them in terms of prognosis (1, 2, 28) . In fact, BMT patients seem to be the only cancer group in which mortality remains significantly high (37, 38) . Also, with respect to differences in standards of care, since this is a single-center study, we cannot exclude possible selection biases that may have occurred involving do-notresuscitate orders and admission/discharge ICU policies. Decisions to withhold or withstand life-sustaining therapies independently predict hospital death in ICU patients (39) . Nonetheless, our ICU policies to implement EOL care are similar to those reported (7, 9, 40) . Finally, increases in SOFA score may predict death independently of the initial score (41) . Nevertheless, in our study, data collection was restricted to the first day of ICU. 
CONCLUSIONS
Although the mortality rate in our study was high, it was lower than those reported in the past decade (1, 2, 7 
